---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-014093"
form_type: "8-K"
ticker: "LMAT"
cik: "0001158895"
company_name: "LEMAITRE VASCULAR INC"
filed_at: "2025-05-01T23:59:59+00:00"
generated_at: "2026-05-22T23:45:30.047549+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# LeMaitre Vascular Q1 sales $59.9M (+12% YoY), raises FY guidance, declares $0.20 dividend

## Summary
- Q1 sales $59.9M, +12% reported (+13% organic); EPS $0.48, +10% YoY.
- FY 2025 sales guidance raised to $242-249M (mid $245M, +13% organic) from prior $239M.
- Quarterly dividend of $0.20/share declared, payable May 29 to holders of record May 15.
- Artegraft received MDR CE Mark on April 29; European launch to begin.
- Ended Elutia porcine patch distribution agreement on April 30 (U.S. hospital sales $5.0M in 2024).

## SEC filing metadata
- accession: 0001437749-25-014093
- form_type: 8-K
- ticker: LMAT
- cik: 0001158895
- company_name: LEMAITRE VASCULAR INC
- filed_at: 2025-05-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1158895/000143774925014093/0001437749-25-014093-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1158895/000143774925014093/lmat20250501_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-014093
- JSON: https://secwatch.observer/filing/0001437749-25-014093.json
- Plain text: https://secwatch.observer/filing/0001437749-25-014093.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.